SE9804192D0 - New formulation - Google Patents
New formulationInfo
- Publication number
- SE9804192D0 SE9804192D0 SE9804192A SE9804192A SE9804192D0 SE 9804192 D0 SE9804192 D0 SE 9804192D0 SE 9804192 A SE9804192 A SE 9804192A SE 9804192 A SE9804192 A SE 9804192A SE 9804192 D0 SE9804192 D0 SE 9804192D0
- Authority
- SE
- Sweden
- Prior art keywords
- cyclosporin
- composition
- monoglycerides
- lipids
- new formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Dispersion Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
A pharmaceutical composition comprising a cyclosporin as an active substance in a lipid carrier, which carrier comprises membrane lipids in combination with monoglycerides and optionally non-polar lipids, which composition is characterized in being liquid at room temperature and containing 0.5-25 % cyclosporin, 10-45 % membrane lipids, 10-55 % monoglycerides and 0-45 % non-polar lipids. A composition of the invention is bioequivalent to a commercial drug containing in addition to cyclosporin and additives also toxic emulsifiers and ethanol.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9804192A SE9804192D0 (en) | 1998-12-03 | 1998-12-03 | New formulation |
EP99963798A EP1135152A1 (en) | 1998-12-03 | 1999-12-03 | A pharmaceutical composition comprising cyclosporin in a lipid carrier |
PCT/SE1999/002259 WO2000032219A1 (en) | 1998-12-03 | 1999-12-03 | A pharmaceutical composition comprising cyclosporin in a lipid carrier |
CA002352388A CA2352388A1 (en) | 1998-12-03 | 1999-12-03 | A pharmaceutical composition comprising cyclosporin in a lipid carrier |
NZ512194A NZ512194A (en) | 1998-12-03 | 1999-12-03 | A pharmaceutical composition comprising cyclosporin in a lipid carrier |
AU20167/00A AU764413B2 (en) | 1998-12-03 | 1999-12-03 | A pharmaceutical composition comprising cyclosporin in a lipid carrier |
JP2000584910A JP2002531412A (en) | 1998-12-03 | 1999-12-03 | Pharmaceutical composition comprising cyclosporin in a lipid carrier |
HU0105399A HUP0105399A3 (en) | 1998-12-03 | 1999-12-03 | Pharmaceutical composition comprising cyclosporin in a lipid carrier |
PL99348062A PL348062A1 (en) | 1998-12-03 | 1999-12-03 | A pharmaceutical composition comprising cyclosporin in a lipid carrier |
NO20012736A NO20012736L (en) | 1998-12-03 | 2001-06-01 | Pharmaceutical composition comprising cyclosporin in a lipid carrier |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9804192A SE9804192D0 (en) | 1998-12-03 | 1998-12-03 | New formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9804192D0 true SE9804192D0 (en) | 1998-12-03 |
Family
ID=20413540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9804192A SE9804192D0 (en) | 1998-12-03 | 1998-12-03 | New formulation |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1135152A1 (en) |
JP (1) | JP2002531412A (en) |
AU (1) | AU764413B2 (en) |
CA (1) | CA2352388A1 (en) |
HU (1) | HUP0105399A3 (en) |
NO (1) | NO20012736L (en) |
NZ (1) | NZ512194A (en) |
PL (1) | PL348062A1 (en) |
SE (1) | SE9804192D0 (en) |
WO (1) | WO2000032219A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0200475D0 (en) * | 2002-02-15 | 2002-02-15 | Ltp Lipid Technologies Provide | Oral pharmaceutical preparation |
US20050058671A1 (en) * | 2003-05-09 | 2005-03-17 | Bedding Peter M.J. | Dietary supplement and method for treating digestive system-related disorders |
SE0303135D0 (en) * | 2003-11-25 | 2003-11-25 | Lipocore Holding Ab | Controlled food effect composition |
SE0401942D0 (en) * | 2004-07-28 | 2004-07-28 | Lipopeptide Ab | New antimicrobial peptide complexes |
US20090041829A1 (en) * | 2005-04-28 | 2009-02-12 | Galenica Technology Ab | Pharmaceutical dosage forms comprising a lipid phase |
EP2699267A4 (en) * | 2011-04-18 | 2014-11-12 | Lipidor Ab | Liquid carrier for oral delivery of a pharmacologically active agent |
JP6242582B2 (en) * | 2013-04-01 | 2017-12-06 | ポーラ化成工業株式会社 | Method for producing reverse vesicle composition |
JP6242581B2 (en) * | 2013-04-01 | 2017-12-06 | ポーラ化成工業株式会社 | Method for producing reverse vesicle composition |
JP6334151B2 (en) * | 2012-12-25 | 2018-05-30 | ポーラ化成工業株式会社 | Reverse vesicle composition |
WO2014103742A1 (en) * | 2012-12-25 | 2014-07-03 | ポーラ化成工業株式会社 | Reverse vesicle composition and method for producing same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0148748B1 (en) * | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | A multiphase cyclosporin composition |
US5529785A (en) * | 1993-05-12 | 1996-06-25 | Dietl; Hans | Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same |
PL178394B1 (en) * | 1994-02-04 | 2000-04-28 | Scotia Lipidteknik Ab | Lipophylic carrier preparations |
IL129547A (en) * | 1994-10-26 | 2001-01-11 | Novartis Ag | Pharmaceutical compositions comprising a macrolide and an acid |
IT1289939B1 (en) * | 1997-02-20 | 1998-10-19 | Angelini Ricerche Spa | AQUEOUS PHARMACEUTICAL COMPOSITION INCLUDING A HIGHLY WATER INSOLUBLE ACTIVE SUBSTANCE |
US6063762A (en) * | 1997-12-05 | 2000-05-16 | Chong Kun Dang Corp. | Cyclosporin-containing microemulsion preconcentrate composition |
-
1998
- 1998-12-03 SE SE9804192A patent/SE9804192D0/en unknown
-
1999
- 1999-12-03 AU AU20167/00A patent/AU764413B2/en not_active Ceased
- 1999-12-03 EP EP99963798A patent/EP1135152A1/en not_active Withdrawn
- 1999-12-03 HU HU0105399A patent/HUP0105399A3/en unknown
- 1999-12-03 PL PL99348062A patent/PL348062A1/en not_active Application Discontinuation
- 1999-12-03 CA CA002352388A patent/CA2352388A1/en not_active Abandoned
- 1999-12-03 JP JP2000584910A patent/JP2002531412A/en active Pending
- 1999-12-03 NZ NZ512194A patent/NZ512194A/en unknown
- 1999-12-03 WO PCT/SE1999/002259 patent/WO2000032219A1/en not_active Application Discontinuation
-
2001
- 2001-06-01 NO NO20012736A patent/NO20012736L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20012736D0 (en) | 2001-06-01 |
EP1135152A1 (en) | 2001-09-26 |
CA2352388A1 (en) | 2000-06-08 |
HUP0105399A3 (en) | 2005-06-28 |
NO20012736L (en) | 2001-06-01 |
AU764413B2 (en) | 2003-08-21 |
NZ512194A (en) | 2002-09-27 |
AU2016700A (en) | 2000-06-19 |
WO2000032219A1 (en) | 2000-06-08 |
PL348062A1 (en) | 2002-05-06 |
HUP0105399A2 (en) | 2002-06-29 |
JP2002531412A (en) | 2002-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS6344A (en) | Pharmaceutical formulations leading to increased drug concentrations | |
RS49838B (en) | Long acting injectable formulations containing hydrogenated castor oil | |
KR890700036A (en) | Nasal preparations and preparation methods thereof | |
KR950007841A (en) | Sustained-release drug formulations containing tramadol salts | |
ES2126766T3 (en) | TROPYL 7-AZAINDOL-3-ILCARBOXIAMIDES AS ANTI-TUSSIVE AGENT. | |
CA2416383A1 (en) | Solution-, dispersion- or emulsion-producing film dermatics | |
DK0851753T3 (en) | aerosol | |
ATE143830T1 (en) | MICROCAPSULES WITH WALLS MADE OF POLYSACCHARIDES CONTAINING PRIMARY ALCOHOL FUNCTIONS, AND COMPOSITIONS THEREOF | |
NZ509418A (en) | Pharmaceutical formulations for aerosols with two or more active substances | |
ATE226815T1 (en) | MANUFACTURING OF MEDICINAL PRODUCTS | |
DE69917609D1 (en) | MEDICINAL PRODUCTS AND THE USE THEREOF | |
SE9804192D0 (en) | New formulation | |
ATE353009T1 (en) | PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH SOFT GELATIN FORMULATIONS | |
BR0111678A (en) | Medicinal compositions containing propenone derivatives | |
IT1263840B (en) | ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF CAPSULES | |
NO20055601L (en) | Pharmaceutical preparation in the form of a hydrogel for transdermal administration of active ingredients | |
SE9800729D0 (en) | New topical formulation I | |
SE9403389D0 (en) | Pharmaceutical composition containing derivatives of sex hormones | |
DE69616783T2 (en) | OSMOTIC DEVICE WITH A HIGH CONTENT OF ACTIVE SUBSTANCES AND DELAYED ACTIVATION OF THE ACTIVE SUBSTANCE RELEASE | |
DE60007074D1 (en) | SULFATED PHOSPHATIDYLINOSITOLS, THEIR PRODUCTION AND USE | |
HUP0004362A2 (en) | Parenteral formulations comprising carbamazepine or its derivatives | |
ATE227509T1 (en) | INHIBITOR AND PRESERVATIVE COMPOSITION | |
KR970061251A (en) | Antifungal External Composition | |
DE59801586D1 (en) | DICLOFENAC SOLUTION DETERMINED FOR TOPICAL APPLICATION | |
AR000922A1 (en) | PRODUCTS TO FIGHT HARMFUL FUNGI CONTAINING P-HYDROXYPHENYLANILINE DERIVATIVES AS AN ACTIVE AGENT, APPLICATION OF SUCH DERIVATIVES TO COMBAT HARMFUL FUNGI AND PROCEDURE TO FIGHT HARMFUL FUNGI WITH APPLICATION OF SUCH PRODUCTS. |